Glaxo and Vir Biotechnology Inc. received U.S. emergency-use authorization for their product last month after it showed it could kept at-risk patients ...
News
- Astra's Antibody Cocktail Fails to Stop Covid-19 in Study
- Southwest National Primate Research Center at Texas Biomed receives $37 million NIH grant
SAN ANTONIO (June 15, 2021) - The Southwest National Primate Research Center (SNPRC) at Texas Biomedical Research Institute (Texas Biomed) ...
- Alamo City research contributes to potential new Covid vaccine
Maryland-based biotech Novavax shared its findings on Monday from a Phase 3 clinical trial involving UT Health San Antonio and University Health, ...
- PetVivo Holdings, Inc. Releases Conference and Exhibit Schedule for 2021-2022
American Association of Equine Practitioners November 18-22 San Antonio, Texas ... PetVivo Holdings Inc. (OTCQB: PETV) is an emerging biomedical device company currently focused on the manufacturing, commercialization and ...
- Advaxis: Fiscal Q2 Earnings Snapshot
The biotechnology company posted revenue of $1.4 million in the period. In the final minutes of trading on Monday, the company's shares hit 50 cents. A ...